Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,219,203
+$69,590 QoQ
Shares Held
16,613
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#1,737
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. JNJ ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,219,203 | 16,613 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,149,613 | 16,976 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,558,712 | 17,196 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,328,474 | 17,951 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,667,167 | 17,461 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,050,792 | 18,396 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,698,753 | 18,661 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,584,208 | 15,946 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,330,667 | 15,946 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,554,768 | 16,150 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,533,702 | 16,165 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,508,353 | 16,105 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,686,058 | 16,228 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,521,540 | 16,268 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,898,473 | 16,408 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,693,479 | 16,488 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,927,672 | 16,493 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,981,894 | 16,825 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,880,134 | 16,836 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,622,760 | 16,240 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,649,348 | 16,082 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,648,500 | 16,115 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,533,818 | 16,100 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $2,404,412 | 16,150 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,271,174 | 16,150 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $2,129,026 | 16,236 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||